Clinical Trials-India-Need for transparency

Clinical Trials-India-Need for transparency

More than 650 clinical trials are currently taking place in the country and all the leading global pharmaceutical companies such as Astra Zeneca, BMS, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer and Sanofi Aventis have started moving their key trials to India. India has a large number of patients in 'currently' hot areas for clinical research, like diabetes, cardiovascular disease, HIV and oncology.

It is obvious that the staff at Central Drugs Standard Control Organisation (CDSCO), has a tricky task at hand to bring in transparency and accountability. The global clinical research market is pegged at around $20 billion with India's share being about $485 million. The latter is projected to cross the $1 billion mark by 2015, estimates Frost & Sullivan. Clinical trials are needed and new medicines are imperative, but more than the investment that would come in, the bigger task at hand is to ensure safety of volunteers and generate quality data.

Source: http://blogs.veedacr.com/Lists/Posts/Post.aspx?ID=348